Abbott Laboratories DL-Notes 2016(16/26)
- BID
99.8
- ASK
99.96
- 500,000 Nom.500,000 Nom.
- 07/27, 16:24:20 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
4.40
Yield spread Bundesanleihe
1.5706
Tradable for private investors
No
Minimum amount tradeable unit
2,000.00
Maturity
30/11/2026
Interest Rate
3.75 %
Currency
US Dollar
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE / YIELD | 99.8 G / 4.40 | 0 Units |
| PRICE DETERMINATION TIME | 07/27/2026 / 04:01:34 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 1.5706 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 99.81 | 99.79 |
| PREV. DAY'S PRICE | 99.806 | (07/24) |
| CHANGE DAY BEFORE | -0.01 | -0.01 % |
| 52 WEEK HIGH / LOW | 100.017 (02/18) | 99.35 (08/01) |
Master Data
| WKN | A189MR |
| ISIN | US002824BF69 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Abbott Laboratories |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 3.75 % |
| INTEREST RUN FROM | 22/11/2016 |
| NEXT INTEREST PAYMENT | 30/05/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | - |
| TRADING CURRENCY / NOTATION | US Dollar/ Percent |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 3.00 Bil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 2,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 30/11/2026 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Local currency bond: USD. Make Whole Call Option. Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.